Indirect treatment comparison of nivolumab versus placebo for the adjuvant treatment of melanoma
<p><strong>Introduction</strong></p> Until recently, adjuvant treatment options for stage III and IV resectable melanoma have been limited. <p>Patients were often managed through routine surveillance. The phase III randomised controlled trial (RCT) CheckMate 238 (238) d...
| Egile Nagusiak: | , , , , , , |
|---|---|
| Formatua: | Journal article |
| Hizkuntza: | English |
| Argitaratua: |
Elsevier
2020
|